Vyant Bio, Inc.
VYNTDelisted May 4, 2023- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001349929
Vyant Bio, Inc. was delisted on May 4, 2023; its insiders filed their last Form 4 on Feb 27, 2023; 17 institutions reported holding it in 13F filings for Q1 2023, worth $136.8K in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Vyant Bio, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- +4 vs. Q3 2021
- Shares held
- 2.31M
- +53.3K (+2.4%) vs. Q3 2021
- Total value
- $3.12M
- −$2.14M (−40.7%) vs. Q3 2021
- New holders
- 6
- 3 more added
- Sold out
- 2
- 3 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VYNT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 1 | $1 |
| Q1 2023 | 17 | $136.8K |
| Q4 2022 | 17 | $222.1K |
| Q3 2022 | 26 | $949.3K |
| Q2 2022 | 21 | $1.47M |
| Q1 2022 | 23 | $2.54M |
| Q4 2021 | 27 | $3.12M |
| Q3 2021 | 23 | $5.27M |
| Q2 2021 | 29 | $8.41M |
| Q1 2021 | 18 | $2.96M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Vyant Bio, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 850,385 | $1.15M | 0.00% | −1,122−0.1% | Reduced |
| BlackRock Inc. | 213,667 | $288.0K | 0.00% | +3,207+1.5% | Added |
| Blankinship & Foster, LLC | 205,094 | $277.0K | 0.10% | 00.0% | Unchanged |
| Frontier Wealth Management LLC | 202,601 | $274.0K | 0.02% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 188,802 | $254.0K | 0.00% | 00.0% | Unchanged |
| Cerity Partners LLC | 119,535 | $161.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 96,342 | $130.0K | 0.00% | −12,858−11.8% | Reduced |
| State Street Corp | 65,671 | $89.0K | 0.00% | 00.0% | Unchanged |
| Taylor Wealth Management Partners | 47,946 | $65.0K | 0.02% | −34,251−41.7% | Reduced |
| Virtu Financial LLC | 47,137 | $64.0K | 0.01% | +47,137 | New |
| Northern Trust Corp | 43,901 | $59.0K | 0.00% | 00.0% | Unchanged |
| First Republic Investment Management, Inc. | 41,009 | $55.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 38,050 | $51.0K | 0.00% | 00.0% | Unchanged |
| Jackson Square Capital, LLC | 30,389 | $41.0K | 0.01% | 00.0% | Unchanged |
| Millennium Management LLC | 23,539 | $32.0K | 0.00% | +7,429+46.1% | Added |
| Susquehanna International Group, LLP | 22,900 | $31.0K | 0.00% | +22,900 | New |
| Country Club Trust Company, n.a. | 20,000 | $28.0K | 0.00% | 00.0% | Unchanged |
| NorthRock Partners, LLC | 18,832 | $25.0K | 0.00% | 00.0% | Unchanged |
| Carlson Capital Management | 11,800 | $16.0K | 0.00% | 00.0% | Unchanged |
| AE Wealth Management LLC | 10,833 | $15.0K | 0.00% | +10,833 | New |
| UBS Group AG | 10,041 | $14.0K | 0.00% | +10,041 | New |
| Tower Research Capital LLC (TRC) | 4,039 | $5.00K | 0.00% | +583+16.9% | Added |
| US Bancorp | 800 | $1.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 162 | $0 | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 50 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 50 | $0 | 0.00% | +50 | New |
| Cornerstone Advisory, LLC | 17 | $0 | 0.00% | +17 | New |
| Royal Bank of Canada | 0 | $0 | 0.00% | −256−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −400−100.0% | Sold out |